27 results
SC TO-C
EX-2.1
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Information about tender offer
5:29pm
knowledge, or the knowledge that could reasonably be expected to have been discovered by virtue of conducting a reasonable investigation, of those … investigation” does not require that the Company or any individual listed in Section 1.1(a) of the Company Disclosure Schedules or any other Person
8-K
EX-2.1
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Tender and Support Agreement
7:42am
of conducting a reasonable investigation, of those individuals listed in Section 1.1(a) of the Company Disclosure Schedule; provided, that with respect … to matters involving Intellectual Property, “reasonable investigation” does not require that the Company or any individual listed in Section 1.1
8-K
EX-10.2
ZYNE
Zynerba Pharmaceuticals, Inc.
21 Jul 22
Entry into a Material Definitive Agreement
7:07am
or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental … , which consent shall not be unreasonably withheld. Such indemnity shall remain in full force and effect regardless of any investigation made
8-K
EX-10.1
rp6sx8lrv4
21 Jul 22
Entry into a Material Definitive Agreement
7:07am
8-K
EX-99.1
nrq7xsja
26 May 21
In the United States District Court for the District of Delaware
7:01am
8-K
EX-10.1
2jbvfbfucwhe28x
30 Aug 19
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-1.1
azlsf 46asqw8
20 Jul 18
Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:29pm
10-K
fa74j002g4
14 Mar 16
Annual report
12:00am
DRS/A
EX-10.27
fscv bbiixizq4pnoniz
20 Feb 15
Draft registration statement (amended)
12:00am